Voluntary corporate emissions targets not enough to create real climate action
Imperial and CNRS strengthen UK-France science with new partnerships
New AI startup accelerator led by Imperial opens for applications
Imperial ECMC's main objectives are to develop novel imaging, biomarker and therapeutic approaches that will aid cancer diagnosis and treatment.
Top links